Open Access

Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants

David J. Dowling
ImmunoHorizons July 1, 2018, 2 (6) 185-197; DOI: https://doi.org/10.4049/immunohorizons.1700063

Article Information

vol. 2 no. 6 185-197
DOI 
https://doi.org/10.4049/immunohorizons.1700063
PubMed 
31022686
Published By 
The American Association of Immunologists, Inc.
Online ISSN 
2573-7732
History 
  • Received December 18, 2017
  • Accepted June 8, 2018
  • Published online July 2, 2018.
Copyright & Usage 
Copyright © 2018 The Authors This article is distributed under the terms of the CC BY-NC 4.0 Unported license.

Author Information

  1. David J. Dowling
  1. Division of Infectious Diseases, Department of Medicine, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115
  1. Address correspondence and reprint requests to:
    Dr. David J. Dowling, Division of Infectious Diseases, Enders Research Laboratories, Room 730, Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. E-mail address: david.dowling{at}childrens.harvard.edu
View Full Text

Article usage

Article usage: July 2018 to September 2019

AbstractFullPdf
Jul 20180597124
Aug 20181561150
Sep 2018024180
Oct 2018032582
Nov 2018032286
Dec 2018029476
Total 201812340598
Jan 201910351105
Feb 20193539790
Mar 2019112437115
Apr 2019141506117
May 2019110711111
Jun 201966826118
Jul 2019152788101
Aug 201928078095
Sep 2019277598104
Total 201911835394956
Total118477341554

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section